|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific Meetings
|
5R13AT009161-03
|
$5,000
|
$5,000
|
PRICE, THEODORE
|
AMERICAN PAIN SOCIETY
|
|
Yale Cancer Biology Training Grant
|
5T32CA193200-03
|
$229,769
|
$229,769
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
|
5UM1CA186716-04
|
$500,917
|
$500,917
|
MEHNERT, JANICE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
|
5K12CA167540-07
|
$810,000
|
$810,000
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
ViKTriY Early Clinical Trials Consortium (ECTC)
|
5UM1CA186689-04
|
$1,325,865
|
$1,325,865
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis
|
5R01CA181648-05
|
$311,847
|
$311,847
|
LANG, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma
|
1R01CA222253-01
|
$381,997
|
$381,997
|
COLLA, SIMONA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
5R01CA211681-02
|
$504,721
|
$504,721
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
USING RADIOMICS TO IMPACT RADIOTHERAPY TREATMENT PLANNING - Moonshot
|
261201800011C
|
$225,000
|
$225,000
|
N/A
|
HEALTHMYNE, INC.
|
|
Using extracellular metabolites to understand and revert protumoral effects of Tumor-Associated Macrophages
|
5R00CA191021-04
|
$249,000
|
$249,000
|
CARMONA-FONTAINE, CARLOS
|
NEW YORK UNIVERSITY
|
|
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
|
ZIC SC 006537
|
$732,342
|
$732,342
|
Figg, William
|
CCR (NCI)
|
|
USDA/NCI DCP FY 2018 IAA - ACN 18003-001-00000 - USDA - DIET-GENETIC INTERACTIONS - EXAMINE ABSORPTION OF ISOTHIOCYANATES & CAROTENOIDS DERIVED FROM FREEZE-DRIED BROCCOLI
|
ACN 18003-00
|
$181,500
|
$181,500
|
N/A
|
UNITED STATES DEPT OF AGRICULT
|
|
USDA - NUTRIENT INTERACTION - IMMUNE-PREVENTIVE EFFECTS OF I3C/DIM IN CITROBACTER RODENTIUM-INFECTED MOUSE MODEL
|
ACN18001-001
|
$65,000
|
$65,000
|
-, -
|
UNITED STATES DEPT OF AGRICULT
|
|
USAG PYMT
|
ACO17004-001
|
$9,041,735
|
$9,041,735
|
-, -
|
UNITED STATES DEPARTMENT OF THE ARMY
|
|
UPON PROVISIONING THE BASE PLATFORM FOR THE PILOT AND PROVIDING ACCESS FOR UP TO 125 NCI USERS -- CATALOG : NA
|
271201800020I
|
$1,250,000
|
$1,250,000
|
N/A
|
PALANTIR TECHNOLOGIES INC.
|
|
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
|
5K08CA181475-06
|
$140,454
|
$140,454
|
VENNETI, SRIRAM
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Unphosphorylated STAT recruits HP1 for gene repression
|
5R03CA212727-02
|
$77,500
|
$77,500
|
LI, WILLIS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Unlocking the Potential of PI3K Inhibition in CLL
|
5R01CA213442-02
|
$596,117
|
$596,117
|
BROWN, JENNIFER
|
DANA-FARBER CANCER INST
|
|
Understanding Retroviral Reverse Transcription, Recombination, and Replication
|
ZIA BC 010504
|
$228,049
|
$228,049
|
Hu, Wei-Shau
|
CCR (NCI)
|
|
Understanding Long Tail Driver Mutations in Cancer
|
5R01CA204749-02
|
$392,078
|
$392,078
|
TAYLOR, BARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding IDH mutant gliomas
|
ZIA BC 011841
|
$67,687
|
$67,687
|
Wu, Jing
|
CCR (NCI)
|
|
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
|
5R01CA143130-08
|
$721,272
|
$721,272
|
NAKAGAWA, MAYUMI
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Ultrasound Molecular Imaging to Assess Therapeutic Response
|
5R01CA195051-04
|
$572,327
|
$572,327
|
BORDEN, MARK
|
UNIVERSITY OF COLORADO
|
|
Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution
|
ZIA BC 011699
|
$385,873
|
$385,873
|
Kearney, Mary
|
CCR (NCI)
|
|
UFM1 signaling in DNA damage response and cancer therapy
|
1R01CA217183-01A1
|
$363,713
|
$363,713
|
LOU, ZHENKUN
|
MAYO CLINIC ROCHESTER
|
|
Ubiquitination and the DNA Damage Response Pathway
|
5R01CA130996-10
|
$357,750
|
$357,750
|
LOU, ZHENKUN
|
MAYO CLINIC ROCHESTER
|
|
Ubiquitin signaling for protein degradation
|
ZIA BC 011490
|
$1,003,463
|
$1,003,463
|
Walters, Kylie
|
CCR (NCI)
|
|
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications
|
5R21CA212500-02
|
$188,125
|
$188,125
|
MOHS, AARON
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Tumor-associated neutrophils in human lung cancer
|
5R01CA187392-03
|
$366,000
|
$366,000
|
ERUSLANOV, EVGENIY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$388,703
|
$388,703
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor suppression, p53 and retrotransposons
|
1R01CA222579-01
|
$370,575
|
$370,575
|
ABRAMS, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Tumor Metabolism
|
1R13CA221318-01
|
$4,000
|
$4,000
|
PETERSON, JANE
|
KEYSTONE SYMPOSIA
|
|
Triad1 regulates myelopoiesis and functions as a leukemia suppressor
|
5R01CA195642-04
|
$353,419
|
$353,419
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Translesion DNA polymerase kappa activity in gliomas
|
5R01CA183895-05
|
$303,075
|
$303,075
|
EOFF, ROBERT
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$183,408
|
$183,408
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Breast Cancer Research Training Program
|
1T32CA203690-01A1
|
$194,523
|
$194,523
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Transgenic Core Facility
|
ZIC BC 010903
|
$714,504
|
$714,504
|
Swing, Deborah
|
CCR (NCI)
|
|
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
|
5R01CA204115-02
|
$588,621
|
$588,621
|
FIELDS, RYAN
|
WASHINGTON UNIVERSITY
|
|
Towards a non-invasive molecular test for bladder cancer
|
5R01CA116161-09
|
$373,690
|
$373,690
|
GOODISON, STEVE
|
MAYO CLINIC JACKSONVILLE
|
|
TOPIC 379 - PHASE I: DIGIBIOMARC: DIGITAL BIOMARKERS FOR CLINICAL IMPACT - Moonshot
|
261201800010C
|
$224,294
|
$224,294
|
N/A
|
MEDABLE INC.
|
|
TOPIC 379 - PHASE I - EXTENSIBLE AND SCALABLE PLATFORM FOR DATA INTEGRATION FROM WEARABLE SENSORS TO GENERATE NOVEL ANALYTICS FOR CANCER PATIENTS- Moonshot
|
261201800009C
|
$224,759
|
$224,759
|
N/A
|
LITMUS HEALTH, INC.
|
|
TOPIC 377 - KLESIS, LLC - PHASE I CONTRACT - Moonshot
|
261201800022C
|
$225,000
|
$225,000
|
N/A
|
KLESIS, LLC
|
|
TOPIC 377 - COGNITIVE MEDICAL SYSTEMS, INC. - PHASE I CONTRACT - Moonshot
|
261201800020C
|
$225,000
|
$225,000
|
N/A
|
COGNITIVE MEDICAL SYSTEMS, INC.
|
|
TOPIC 377 - CAREVIVE SYSTEMS - PHASE I CONTRACT - Moonshot
|
261201800021C
|
$225,000
|
$225,000
|
N/A
|
CAREVIVE SYSTEMS, INC.
|
|
TOPIC 376 PHASE 1 - Moonshot
|
261201800024C
|
$299,641
|
$299,641
|
N/A
|
CELLSIGHT TECHNOLOGIES, INC.
|
|
TOPIC 376 - INLIGHTA BIOSCIENCES, LLC - PHASE I CONTRACT - Moonshot
|
261201800025C
|
$298,230
|
$298,230
|
N/A
|
INLIGHTA BIOSCIENCES L.L.C.
|
|
TOPIC 375: 18F PET TRACER FOR IMAGING PD-L1 - Moonshot
|
261201800027C
|
$299,735
|
$299,735
|
N/A
|
SIBTECH, INC
|
|
TOPIC 373 - PHASE I SBIR MOONSHOT CONTRACT - Moonshot
|
261201800034C
|
$299,438
|
$299,438
|
N/A
|
RIBONOVA INC.
|
|
TOPIC 373 - PHASE I SBIR MOONSHOT CONTRACT - ELECTRONIC BIOSCIENCES INC. - Moonshot
|
261201800033C
|
$299,999
|
$299,999
|
N/A
|
ELECTRONIC BIOSCIENCES, INC.
|
|
TOPIC 373 - PHASE I SBIR MOONSHOT CONTRACT - DIGITAL NANOGENETICS, INC. - Moonshot
|
261201800032C
|
$300,000
|
$300,000
|
N/A
|
DIGITAL NANOGENETICS LLC
|
Total relevant funding to Cancer for this search: $1,434,732,845
|